These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26718439)

  • 21. Down-regulation of P-glycoprotein expression by sustained intracellular acidification in K562/Dox cells.
    Lu Y; Pang T; Wang J; Xiong D; Ma L; Li B; Li Q; Wakabayashi S
    Biochem Biophys Res Commun; 2008 Dec; 377(2):441-446. PubMed ID: 18851949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
    Chen LM; Liang YJ; Zhang X; Su XD; Dai CL; Wang FP; Yan YY; Tao LY; Fu LW
    Anticancer Res; 2009 Nov; 29(11):4597-604. PubMed ID: 20032409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression.
    Chen P; Liu Y; Sun Y; Chen C; Qi Y; Zhang Y
    Pharm Biol; 2013 Dec; 51(12):1586-91. PubMed ID: 24004004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
    Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
    Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance.
    Qi J; Yang CZ; Wang CY; Wang SB; Yang M; Wang JH
    Acta Pharmacol Sin; 2002 Jun; 23(6):544-50. PubMed ID: 12060530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of CJY, an isoflavone, with ATPase of P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Cen J; Liu L; He L; Ji BS
    Drug Res (Stuttg); 2013 Aug; 63(8):429-34. PubMed ID: 23720244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
    Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
    Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).
    Orlandi F; Coronnello M; Bellucci C; Dei S; Guandalini L; Manetti D; Martelli C; Romanelli MN; Scapecchi S; Salerno M; Menif H; Bello I; Mini E; Teodori E
    Bioorg Med Chem; 2013 Jan; 21(2):456-65. PubMed ID: 23245571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of P-glycoprotein and glutathione S-transferase-pi mediated resistance by fluoxetine in MCF-7/ADM cells.
    Zhang Y; Zhou T; Duan J; Xiao Z; Li G; Xu F
    Biomed Pharmacother; 2013 Oct; 67(8):757-62. PubMed ID: 23731711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reversal effect of haloperidol on doxorubicin resistance and chloride channel inhibition in erythroleukemic cell K562/Dox].
    Zhou JH; Wu DZ
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):81-5. PubMed ID: 15946544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell lines.
    Xu HB; Li L; Liu GQ
    Chemotherapy; 2011; 57(1):62-70. PubMed ID: 21282948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
    Ma B; Chai S; Li N; To KK; Kan WL; Yang D; Lin G
    Int J Pharm; 2012 Mar; 424(1-2):33-9. PubMed ID: 22226881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
    Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
    Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
    Li R; Wu R; Zhao L; Wu M; Yang L; Zou H
    ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.